Complement component C1q and anti-C1q antibodies in theory and in clinical practice

Scandinavian Journal of Immunology

Volumn 67, Issue 5, 2008, Pages 423-430

  Potlukova, E ^a   Kralikova, P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q ANTIBODY;

APOPTOSIS; AUTOIMMUNE DISEASE; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT SYSTEM; DIAGNOSTIC VALUE; HUMAN; INFECTION; INNATE IMMUNITY; LUPUS ERYTHEMATOSUS NEPHRITIS; NON INVASIVE MEASUREMENT; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; APOPTOSIS; AUTOANTIBODIES; BIOLOGICAL MARKERS; COMPLEMENT C1Q; COMPLEMENT PATHWAY, CLASSICAL; DISEASE PROGRESSION; HUMANS; IMMUNITY, NATURAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS;

EID: 42049120120     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02089.x     Document Type: Review

References (57)

1. Abbas KA, Lichtman AH, Pober JS. Effector mechanisms of humoral immunity. In : Abbas KA, Lichtman AH, Pober JS, ed. Cellular and Molecular Immunology. Philadelphia : WB Saunders, 2000 : 309 34.
2. Schumaker VN, Hanson DC, Kilchherr E, Phillips ML, Poon PH. A molecular mechanism for the activation of the first component of complement by immune complexes. Mol Immunol 1986 23 : 557 65.
3. Siegert CEH, Kazatchkine MD, Sjöholms A, Würzner R, Loos M, Daha MR. Autoantibodies against C1q: view on clinical relevance and pathogenic roles. Clin Exp Immunol 1999 116 : 4 8.
4. Botto M, Dell'Agnola C, Bygrave AE et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998 19 : 56 9.
5. Botto M. Links between complement deficiency and apoptosis. Arthritis Res 2001 3 : 207 10.
6. Taylor PR, Carugati A, Fadok VA et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000 192 : 359 66.
7. Mitchell DA, Pickering MC, Warren J et al. C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J Immunol 2002 168 : 2538 43.
8. Korb LC, Ahearn JM. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systematic lupus erythematosus revisited. J Immunol 1997 158 : 4525 8.
9. Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM. The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol 2001 166 : 3231 9.
10. Gaipl US, Kuenkele S, Voll RE et al. Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death. Cell Death Differ 2001 8 : 327 34.
11. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998 188 : 2313 20.
12. Ogden CA, deCathelineau A, Hoffmann PR et al. C1q and mannose binding lectin engagement of cell surface calcireticulin and CD91 initiates macropinocytosis and uptake of apoptotic bodies. J Exp Med 2001 194 : 781 96.
13. Trendelenburg M. Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin Immunopathol 2005 27 : 276 85.
14. Carroll M. Innate immunity in the etiopathology of autoimmunity. Nat Immunol 2001 2 : 1089 90.
15. Grimbert P, Schulte K, Buisson C et al. Renal transplantation in a patient with hypocomplementemic urticarial vasculitis syndrome. Am J Kidney Dis 2001 37 : 144 8.
16. Berner B, Scheel AK, Schettler V et al. Rapid improvement of SLE-specific cutaneous lesions by C1q immunoadsorption. Ann Rheum Dis 2001 60 : 898 9.
17. Pfueller B, Wolbart K, Bruns A, Burmester GR, Hiepe F. Successful treatment of patients with SLE by immunoadsorption with a C1q column: a pilot study. Arthritis Rheum 2001 44 : 1962 3.
18. Golan MD, Burger R, Loos M. Conformational changes in C1q after binding of immune complexes: detection of neoantigens with monoclonal antibodies. J Immunol 1982 129 : 445 7.
19. Uwatoko S, Gauthier VJ, Mannik M. Autoantibodies to the collagen-like region of C1q deposit in glomeruli via C1q in immune deposits. Clin Immunol Immunopathol 1991 61 : 268 73.
20. Mannik M, Wener M. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum 1997 40 : 1504 11.
21. Trendelenburg M, Marfurt J, Gerber I, Tyndall A, Schifferli JA. Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. Arthritis Rheum 1999 42 : 187 8.
22. Trouw LA, Groeneveld TWL, Seelen MA et al. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest 2004 114 : 679 86.
23. Holers VM. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus. J Clin Invest 2004 114 : 616 9.
24. Botto M, Walport MJ. C1q, autoimmunity and apoptosis. Immunobiology 2002 205 : 395 406.
25. Agnello V, Koffer D, Eisenberg JW, Wichester RJ, Kunkel HG. C1q precipitins in the serum of patients with systemic lupus erythematosus and other hypocomplementemic states: characterisation of high and low molecular weight types. Clin Exp Immunol 1971 134 : 228 41.
26. Marder RJ, Burch FX, Schmid FR, Zeiss CR, Gewurz H. Low molecular weight C1q precipitins in hypocomplementemic vasculitis-urticarial syndrome: partial purification and characterization as immunoglobulin. J Immunol 1978 128 : 613 8.
27. Uwatoko S, Aotsuka S, Okawa M et al. Characterisation of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol 1984 30 : 104 16.
28. Wener MH, Uwatoko S, Mannik M. Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic disease. Arthritis Rheum 1989 32 : 544 50.
29. Siegert CEH, Daha MR, Halma C, van der Voort EAM, Breedveld FC. IgG and IgA autoantibodies to C1q in systemic and renal diseases. Clin Exp Rheumatol 1992 10 : 19 23.
30. Wisnieski JJ, Jones SM. IgG autoantibody to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases. J Rheumatol 1992 19 : 884 8.
31. Wisnieski JJ, Naff GB. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum 1989 32 : 1119 27.
32. Haseley LA, Wisnieski JJ, Denburg MR et al. Antibodies to C1q in systemic lupus erythematosus: characteristics and relation to Tc gamma RIIA alleles. Kidney Int 1997 52 : 1357 80.
33. Siegert CEH, Daha MR, Voort EAM, Breedveld FC. IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis. Arthritis Rheum 1990 33 : 1646 54.
34. Horvath L, Czirjak L, Fekete B et al. Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases. Immunol Lett 2001 75 : 103 9.
35. Potlukova E, Jiskra J, Limanova Z et al. Autoantibodies against complement C1q correlate with the thyroid function in patients with autoimmune thyroid disease. Mol Immunol 2007 44 : 3941 (Abstract).
36. Siegert CE, Daha MR, Swaak AJ, van der Voort EA, Breedveld FC. The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1993 67 : 204 9.
37. Ravelli A, Wisnieski JJ, Ramenghi B, Ballardini G, Zonta L, Martini A. IgG autoantibodies to complement C1q in pediatric-onset systemic lupus erythematosus. Clin Exp Rheumatol 1997 15 : 215 9.
38. Kozyro I, Perahud I, Sadallah S et al. Clinical value of autoantibodies against C1q in children with glomerulonephritis. Pediatrics 2006 117 : 1663 8.
39. Hay FC, Nineham LJ, Roitt IM. Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q. Immunology 1976 24 : 396 400.
40. Trendelenburg M, Lopez-Trascasa M, Potlukova E et al. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant 2006 21 : 3115 21.
41. Kohro-Kawata J, Wener MH, Mannik M. The effect of high salt concentration on detection of serum immune complexes and autoantibodies do C1q in patients with systemic lupus erythematosus. J Rheumatol 2002 29 : 84 9.
42. Wisnieski JJ, Baer AN, Christensen J et al. Hypocomplementemic urticarial vasculitis syndrome. Clinical and serological findings in 18 patients. Medicine 1995 74 : 24 41.
43. Marto N, Bertolaccini ML, Calabuig E, Hughes GRV, Khamashta MA. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis 2005 64 : 444 8.
44. Horváth L, Czirják L, Fekete B et al. High levels of antibodies against C1q are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol 2001 19 : 667 72.
45. Coremans IEM, Spronk PE, Bootsma H et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 1995 26 : 595 601.
46. Siegert CEH, Daha MR, Tseng CMES, Coremans IEM, van Es LA, Breedveld FC. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis 1993 52 : 851 6.
47. Ronnelid J, Huang YH, Norrlander T et al. Short-term kinetics of the humoral anti-C1q response in SLE using the ELISPOT method: fast decline in production in response to steroids. Scand J Immunol 1994 40 : 243 50.
48. Trendelenburg M, Courvoisier S, Spaeth PJ et al. Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus? Am J Kidney Dis 1999 34 : 745 51.
49. Moroni G, Trendelenburg M, Del Papa N et al. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 2001 37 : 490 8.
50. Gunnarson I, Rönnelid J, Huang YH et al. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. Br J Rheumatol 1997 36 : 32 7.
51. Gunnarson I, Sundelin B, Heimbürger M et al. Repeated renal biopsy in proliferative lupus nephritis - predictive role of serum C1q and albuminuria. J Rheumatol 2002 29 : 693 9.
52. Horak P, Hermanova Z, Zadrazil J et al. C1q complement component and - antibodies reflect SLE activity and kidney involvement. Clin Rheumatol 2006 25 : 532 6.
53. Strife CF, Leaby AE, West CD. Antibody to a cryptic, solid phase C1q antigen in membranoproliferative nephritis. Kidney Int 1989 35 : 836 42.
54. Gunnarsson I, Rönnelid J, Lundberg I, Jacobson SH. Occurrence of anti-C1q antibodies in IgA nephropathy. Nephrol Dial Transplant 1997 12 : 2263 8.
55. Tuzun E, Saini SS, Ghosh S, Rowin J, Meriggioli MN, Christados P. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis. Neuromuscul Disord 2006 16 : 137 43.
56. Prohaszka Z, Daha MR, Sasal C et al. C1q autoantibodies in HIV infection: correlation to elevated levels of autoantibodies against 60-kDa heat shock proteins. Clin Immunol 1999 90 : 247 55.
57. Saadoun D, Sadallah S, Trendelenburg M et al. Anti-C1q antibodies in hepatitis C virus infection. Clin Exp Immunol 2006 145 : 308 12.